Cargando…
Recent advances in managing and understanding diabetic nephropathy
Diabetic nephropathy is the commonest cause of end-stage renal disease in most developed economies. Current standard of care for diabetic nephropathy embraces stringent blood pressure control via blockade of the renin-angiotensin-aldosterone system and glycemia control. Recent understanding of the p...
Autores principales: | Tang, Sydney C.W., Chan, Gary C.W., Lai, Kar Neng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892357/ https://www.ncbi.nlm.nih.gov/pubmed/27303648 http://dx.doi.org/10.12688/f1000research.7693.1 |
Ejemplares similares
-
Recent advances in the understanding and management of IgA nephropathy
por: Lai, Kar Neng, et al.
Publicado: (2016) -
The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2023) -
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone
por: Leung, Joseph CK, et al.
Publicado: (2011) -
Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice
por: Wu, Hao Jia, et al.
Publicado: (2017) -
Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management
por: Sulaiman, Mahaboob Khan
Publicado: (2019)